Introduction
Beryllium disease most commonly results from inhalation of the metal or its salts resulting in acute or chronic pulmonary beryllium disease. The other, not infrequent, route is via the skin, producing acute contact dermatitis or, in a chronic form, skin nodules and ulceration. It is of interest that though many industrial workers are potentially exposed, few develop the disease. It is considered that sensitization is an important predetermining factor.
The disease was first recognized as acute pneumonitis in Germany in 19331 and reached the headlines in Salem, Massachusetts with many new cases occurring in fluorescent lamp (beryllium phosphorus) workers.2 Beryllium ceased to be used in the lamp industry in around 1951. Beryllium is a very stable, light metal (atomic weight 9) , extremely hard, has good electric and thermal conductivity, is non-magnetic and is increasingly used in modern industries (Table I) .
The majority of cases have been reported in North America. The USA Case Register established by Dr Harriet Hardy in Boston in 1951, now numbers over 8003 and is continued by the National Institute for Occupational Safety and Health (NIOSH) in Cincinnati. 4 The UK Case Register5 now numbers 60 and, though it is a rare disease, new cases continue to occur.
The criteria for the diagnosis of chronic beryllium disease are now well agreed6: (1) history of exposure; (2) consistent clinical and radiological Be Figure 1 Laser microprobe mass spectrometer analysis of granuloma showing beryllium peak.
The finding of beryllium in urine of suspect patients is of less value than tissue analysis. In the UK series, beryllium was found in less than half the cases examined. It proves exposure and absorption but, as it may be found in healthy beryllium workers, is not proof of disease.
Immunology
Immunological factors in chronic beryllium disease have long been recognized by early workers with the development of the beryllium patch test. 21 
